CytoDyn Inc.

OTCPK:CYDY Stock Report

Market Cap: US$398.1m

CytoDyn Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Jay Lalezari

Chief executive officer

US$783.9k

Total compensation

CEO salary percentage51.03%
CEO tenure2.6yrs
CEO ownershipn/a
Management average tenure2.7yrs
Board average tenure4.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jay Lalezari's remuneration changed compared to CytoDyn's earnings?
DateTotal CompensationSalaryCompany Earnings
Feb 28 2026n/an/a

-US$40m

Nov 30 2025n/an/a

-US$40m

Aug 31 2025n/an/a

-US$23m

May 31 2025US$784kUS$400k

US$2m

Feb 28 2025n/an/a

-US$9m

Nov 30 2024n/an/a

-US$16m

Aug 31 2024n/an/a

-US$21m

May 31 2024US$816kUS$152k

-US$51m

Compensation vs Market: Jay's total compensation ($USD783.85K) is below average for companies of similar size in the US market ($USD2.59M).

Compensation vs Earnings: Jay's compensation has been consistent with company performance over the past year.

CEO

Jay Lalezari (66 yo)

2.6yrs
Tenure
US$783,850
Compensation

Dr. Jacob P. Lalezari, also known as Jay, MD, was Interim Chief Executive Officer at CytoDyn Inc. since November 17, 2023 until January 26, 2024 and serves as it's Chief Executive Officer and principal exe...

Leadership Team

NamePositionTenureCompensationOwnership
Jacob Lalezari
Chief Executive Officer2.6yrsUS$783.85kno data
Robert Hoffman
Chief Financial Officer1.1yrsUS$812.97k0%
$ 0
Tyler Blok
Chief Legal Officer & Corporate Secretary2.8yrsUS$532.49k0.000020%
$ 79.6
Bernie Cunningham
Vice President of Operations3.8yrsno datano data
Scott Hansen
Head of Research & Basic Science3.4yrsno datano data
Max Lataillade
Senior VP & Head of Clinical Development1.7yrsno datano data
2.7yrs
Average Tenure
60yo
Average Age

Experienced Management: CYDY's management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Stephen Simes
Independent Director3.7yrsUS$156.20k0%
$ 0
Karen Brunke
Independent Director4.2yrsUS$138.70k0%
$ 0
Debasish Tripathy
Member of Scientific Advisory Boardno datano datano data
Hope Rugo
Member of Scientific Advisory Board5.8yrsno datano data
Ryan Dunlap
Independent Director3.8yrsUS$156.20k0%
$ 0
Tanya Urbach
Independent Chairman of the Board4.6yrsUS$188.70k0.012%
$ 47.0k
Jonah Sacha
Member of Scientific Advisory Board8.3yrsno datano data
Lishomwa Ndhlovu
Independent Director4.6yrsUS$136.20k0%
$ 0
Jordan Lake
Member of Scientific Advisory Boardno datano datano data
Naoto Ueno
Member of Scientific Advisory Boardno datano datano data
Otto Yang
Member of Scientific Advisory Boardno datano datano data
Clinton Yam
Member of Scientific Advisory Boardno datano datano data
4.6yrs
Average Tenure
58yo
Average Age

Experienced Board: CYDY's board of directors are considered experienced (4.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/12 21:24
End of Day Share Price 2026/06/12 00:00
Earnings2026/02/28
Annual Earnings2025/05/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CytoDyn Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.